Addressing Skyrocketing Cancer Drug Prices Comes With Tradeoffs: Pick Your Poison
JAMA Oncol
.
2016 Apr;2(4):425-6.
doi: 10.1001/jamaoncol.2015.5813.
Authors
Scott D Ramsey
1
,
Gary H Lyman
1
,
Rick Bangs
2
Affiliations
1
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington2Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington.
2
Patient Advocacy Committee, SWOG, Portland, Oregon.
PMID:
26868102
DOI:
10.1001/jamaoncol.2015.5813
No abstract available
MeSH terms
Antineoplastic Agents / economics*
Drug Costs*
Humans
Neoplasms / drug therapy*
Neoplasms / economics*
Substances
Antineoplastic Agents
Grants and funding
UG1 CA189974/CA/NCI NIH HHS/United States